TOBACCO-FREE KIDS ACTION FUND

TOB · Tobacco

Lobbying Report: July 1st - September 30th , 2026 (Action Fund) Federal (under tobacco issue code)   Legislation:   H.R. 6845/S. 3569, Strengthening Task Force Operations to Prevent Illicit Vaping Act (S.T.O.P. Illicit Vaping Act) H.R. 6844, Tracking, Reporting, and Accountability for Compliance in Enforcement Act (Tobacco TRACE Act) H.R. 8845 and Senate bill, FY 27 Commerce, Justice, Science, and Related Agencies Appropriations Act H.R. 9260 and Senate bill, FY 27 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act H.R. 8595 and Senate bill, FY 27 National Security, Department of State, and Related Programs Appropriations Act / State, Foreign Operations, and Related Programs Appropriations Act H.R. 8646 and Senate bill, FY 27 Agriculture, Rural Development, and Related Agencies Appropriations Act S. 4257 Resources to Prevent Youth Vaping Act H.R. 7567 Farm, Food, and National Security Act of 2026 S. 5526 Agricultural Act of 2026 H.R. 2111, to amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations. H.R. 9877/S.5066 Health, Equity, and Accountability Act of 2026 H.R. 10068/S.5312 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act Issues: CDC tobacco prevention and cessation programs and funding Congressional Caucus to End Youth Vaping Federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes FDA oversight of nicotine pouches FDA regulation of tobacco products[LG1.1] Potential Flavors Legislation Potential [LG2.1]Tobacco Control Legislation Regulation of Menthol Cigarettes Tobacco Impact on Maternal Health Tobacco Graphic Warnings Tobacco User Fees OMB Federal financial Assistance Rule [LG3.1] Tobacco Harm Reduction Modified Risk Tobacco Products Agencies Visited:   Food and Drug Administration  US House of Representatives   US Senate Office of Management and Budget Centers for Disease Control and Prevention

Literal federal measure citations: H.R. 6845, S. 3569, H.R. 6844, H.R. 8845, H.R. 9260, H.R. 8595, H.R. 8646, S. 4257, H.R. 7567, S. 5526, H.R. 2111, H.R. 9877, S.5066, H.R. 10068, S.5312

HCR · Health Issues

GHAI Overdose Initiative (under healthcare issue code): Legislation: FY 27 Appropriations bills H.R. 5629- To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect. H.R. 5630- To amend the Public Health Service Act to require additional information in State plans for Substance Use Prevention, Treatment, and Recovery Services block grants. H.R. 2741 - PEER Support Act S.2948 - WORK to Save Lives Act S. 3522 - No Red Tape Act H.R. 2741/ S. 1329 - Providing Empathetic and Effective Recovery (PEER) Support Act H.R. 2586 - Reentry Act H.R. 1510/ S. 1720 - Due Process Continuity of Care Act S. 5425 - Addiction Grants Modernization Act H.R. 9790/S.4941 - Modernizing Opioid Treatment Access Act 2.0 Issues: Medicaid prior authorization requirements Access to addiction treatment services Overdose prevention Racial disparities in overdose deaths Federal grant funding for addiction treatment services and harm reduction interventions Financing (grants) for behavioral health care services and programs Medicaid and Medicare coverage for addiction treatment services Medicaid funding and federal guidance related to harm reduction Medicaid-supported services during incarceration Congressional naloxone training Women in recovery Substance use disorder workforce expansion CDC Injury Prevention Center programs and funding Methadone access Agencies Visited: US House of Representatives US Senate

Literal federal measure citations: H.R. 5629, H.R. 5630, H.R. 2741, S.2948, S. 3522, H.R. 2741, S. 1329, H.R. 2586, H.R. 1510, S. 1720, S. 5425, H.R. 9790, S.4941